ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 97 filers reported holding ENZO BIOCHEM INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $43,000 | -33.8% | 7,880 | -0.6% | 0.01% | -50.0% |
Q4 2017 | $65,000 | -21.7% | 7,925 | 0.0% | 0.02% | -25.0% |
Q3 2017 | $83,000 | -4.6% | 7,925 | 0.0% | 0.02% | +14.3% |
Q2 2017 | $87,000 | -53.7% | 7,925 | -64.7% | 0.02% | -53.3% |
Q1 2017 | $188,000 | -87.9% | 22,420 | -90.0% | 0.04% | -88.4% |
Q4 2016 | $1,554,000 | +35.2% | 223,931 | -0.8% | 0.39% | +34.8% |
Q3 2016 | $1,149,000 | +114800.0% | 225,834 | +126064.2% | 0.29% | – |
Q1 2015 | $1,000 | – | 179 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evermore Global Advisors, LLC | 3,555,233 | $39,250,000 | 9.97% |
CORRADO ADVISORS, LLC | 326,101 | $3,600,000 | 1.97% |
KOPP INVESTMENT ADVISORS LLC | 199,132 | $2,198,000 | 1.97% |
First Light Asset Management, LLC | 403,082 | $4,450,000 | 1.49% |
Millrace Asset Group, Inc. | 115,878 | $1,279,000 | 1.21% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $1,054,000 | 0.69% |
MARATHON CAPITAL MANAGEMENT | 115,000 | $1,270,000 | 0.60% |
Campbell & CO Investment Adviser LLC | 33,513 | $370,000 | 0.34% |
EAM Investors, LLC | 159,930 | $1,766,000 | 0.29% |
ABNER HERRMAN & BROCK LLC | 100,000 | $1,104,000 | 0.21% |